VIO HEALTHTECH LIMITED – Trademark Portfolio

Entity Type: 24

VIO HEALTHTECH LIMITED holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include OVUSENSE. The owner is based in CAMBERLEY.

UNIT 211, BASEPOINT BUSINESS CENTRE

377-399 LONDON ROAD

CAMBERLEY GU15 3HL , GB

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

OVUSENSE
OVUSENSE
Registered 2012

Trademark Classifications

VIO HEALTHTECH LIMITED's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does VIO HEALTHTECH LIMITED have?

VIO HEALTHTECH LIMITED has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does VIO HEALTHTECH LIMITED file in?

VIO HEALTHTECH LIMITED files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are VIO HEALTHTECH LIMITED's most well-known trademarks?

VIO HEALTHTECH LIMITED's registered trademark portfolio includes well-known marks such as OVUSENSE. These are among 1 currently registered trademark in the portfolio.

What is VIO HEALTHTECH LIMITED's trademark registration success rate?

VIO HEALTHTECH LIMITED has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.